Gold Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57K Hold
10
﹤0.01% 193
2026
Q1
$1.53K Hold
10
﹤0.01% 191
2025
Q4
$1.38K Hold
10
﹤0.01% 196
2025
Q3
$1.28K Hold
10
﹤0.01% 196
2025
Q2
$1.23K Hold
10
﹤0.01% 196
2025
Q1
$1.11K Hold
10
﹤0.01% 208
2024
Q4
$973 Hold
10
﹤0.01% 210
2024
Q3
$1.15K Hold
10
﹤0.01% 202
2024
Q2
$1.06K Hold
10
﹤0.01% 207
2024
Q1
$967 Hold
10
﹤0.01% 207
2023
Q4
$1.01K Buy
+10
New +$965 ﹤0.01% 204

Other funds holding NVS

Gold Investment Management's NVS Position: Q2 2026 in Review

Gold Investment Management held its Novartis (NVS) position steady in Q2 2026 at 10 shares worth $1.57K. The position accounts for ﹤0.01% of the portfolio, ranked #193.

Gold Investment Management first reported a position in NVS in Q4 2023 and has held it in 11 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Gold Investment Management held 10 shares of Novartis worth $1.57K as of Q2 2026.
  • Gold Investment Management left its Novartis share count unchanged in Q2 2026.
  • Novartis made up ﹤0.01% of Gold Investment Management's portfolio in Q2 2026, its #193 holding.
  • Gold Investment Management first reported a position in Novartis in Q4 2023 and has held it in 11 quarters since.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Gold Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.